Paper210568
A 32,000-dalton nucleic acid-binding protein from avian retravirus cores possesses DNA endonuclease activity.
Grandgenett DP and 2 others. Virology, 1978. Cited by 160 papers, by iCite.
Cite this record
ConductScience Library. A 32,000-dalton nucleic acid-binding protein from avian retravirus cores possesses DNA endonuclease activity. Papers, record 210568. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/210568
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A 32,000-dalton nucleic acid-binding protein from avian retravirus cores possesses DNA endonuclease activity.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Avian Leukosis Virus | Major topic |
| Avian Myeloblastosis Virus | Major topic |
| DNA Helicases | Major topic |
| Deoxyribonucleases | Major topic |
| Endonucleases | Major topic |
| Viral Proteins | Major topic |
| Avian Sarcoma Viruses |
Source PubMed
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42125293 | Integrase Inhibitors: Redefining HIV-1 Treatment and Future Challenges. | Mo Med | 2026 | https://conductscience.org/library/papers/42125293 | PubMed |
| 39483451 | State of the ART (antiretroviral therapy): Long-acting HIV-1 therapeutics. | Glob Health Med | 2024 | https://conductscience.org/library/papers/39483451 | PubMed |
| 38675945 | Brief Histories of Retroviral Integration Research and Associated International Conferences. | Viruses | 2024 | https://conductscience.org/library/papers/38675945 | PubMed |
| 35891378 | The C-Terminal Domain of HIV-1 Integrase: A Swiss Army Knife for the Virus? | Viruses | 2022 | https://conductscience.org/library/papers/35891378 | PubMed |
| 35632668 | Multimodal Functionalities of HIV-1 Integrase. | Viruses | 2022 | https://conductscience.org/library/papers/35632668 | PubMed |
| 34861940 | Retroviral integrase: Structure, mechanism, and inhibition. | Enzymes | 2021 | https://conductscience.org/library/papers/34861940 | PubMed |
| 29900498 | Nucleoprotein Intermediates in HIV-1 DNA Integration: Structure and Function of HIV-1 Intasomes. | Subcell Biochem | 2018 | https://conductscience.org/library/papers/29900498 | PubMed |
| 28184005 | A C-terminal "Tail" Region in the Rous Sarcoma Virus Integrase Provides High Plasticity of Functional Integrase Oligomerization during Intasome Assembly. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28184005 | PubMed |
| 27239438 | A targeted DNA substrate mechanism for the inhibition of HIV-1 integrase by inhibitors with antiretroviral activity. | FEBS Open Bio | 2016 | https://conductscience.org/library/papers/27239438 | PubMed |
| 26958915 | Retroviral Integrase: Then and Now. | Annu Rev Virol | 2015 | https://conductscience.org/library/papers/26958915 | PubMed |
| 26887497 | Crystal structure of the Rous sarcoma virus intasome. | Nature | 2016 | https://conductscience.org/library/papers/26887497 | PubMed |
| 26322168 | Multifunctional facets of retrovirus integrase. | World J Biol Chem | 2015 | https://conductscience.org/library/papers/26322168 | PubMed |
| 25431615 | The road to HIV-1 integrase inhibitors: the case for supporting basic research. | Future Virol | 2014 | https://conductscience.org/library/papers/25431615 | PubMed |
| 24872410 | Rous sarcoma virus synaptic complex capable of concerted integration is kinetically trapped by human immunodeficiency virus integrase strand transfer inhibitors. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24872410 | PubMed |
| 22762018 | HIV DNA integration. | Cold Spring Harb Perspect Med | 2012 | https://conductscience.org/library/papers/22762018 | PubMed |
| 19563676 | Comparison of metal-dependent catalysis by HIV-1 and ASV integrase proteins using a new and rapid, moderate throughput assay for joining activity in solution. | AIDS Res Ther | 2009 | https://conductscience.org/library/papers/19563676 | PubMed |
| 19490099 | Piecing together the structure of retroviral integrase, an important target in AIDS therapy. | FEBS J | 2009 | https://conductscience.org/library/papers/19490099 | PubMed |
| 12743305 | Molecular and genetic determinants of rous sarcoma virus integrase for concerted DNA integration. | J Virol | 2003 | https://conductscience.org/library/papers/12743305 | PubMed |
| 11581381 | Requirements for minus-strand transfer catalyzed by Rous sarcoma virus reverse transcriptase. | J Virol | 2001 | https://conductscience.org/library/papers/11581381 | PubMed |
| 11264345 | DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro. | J Virol | 2001 | https://conductscience.org/library/papers/11264345 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/210568
GET https://conductscience.org/api/papers/v1/210568/cited_by?page=2